Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice

Cyanidin-3-o-Glucoside Pharmacologically Inhibits Tumorigenesis via Estrogen Receptor β in Melanoma Mice

Expression patterns of estrogen receptors [ERα, ERβ, and G-protein associated ER (GPER)] in melanoma and skin may suggest their differential roles in carcinogenesis. Phytoestrogenic compound cyanidin-3-o-glucoside (C3G) has been shown to inhibit the growth and metastatic potential of melanoma, altho...

Full description

Bibliographic Details
Main Authors: Mei Liu, Yaqi Du, Haiwen Li, Li Wang, Donata Ponikwicka-Tyszko, Weronika Lebiedzinska, Agata Pilaszewicz-Puza, Huijiao Liu, Lijun Zhou, Hanlu Fan, Mingming Wang, Hua You, Slawomir Wolczynnski, Nafis Rahman, Yang-Dong Guo, Xiangdong Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Oncology
Subjects:
estrogen receptor
C3G
CCNB1
apoptosis
melanoma
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01110/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01110/full

Similar Items